| P50 | author | Thomas A. Clark | Q105740731 |
| | Dominique A Caugant | Q57906958 |
| | Lassana Sangaré | Q62569076 |
| P2093 | author name string | Paul A Kristiansen | |
| | Abdoul-Salam Ouédraogo | |
| | Absatou Ky Ba | |
| | Denis Kandolo | |
| | Fabien Diomandé | |
| | Idrissa Sanou | |
| | Jennifer Dolan Thomas | |
| | Rasmata Ouédraogo | |
| | Marc Laforce | |
| P2860 | cites work | Capsule switching and capsule replacement in vaccine-preventable bacterial diseases | Q80832715 |
| | Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex | Q81257710 |
| | Pneumococcal vaccine--direct and indirect ("herd") effects | Q83103217 |
| | Clones of Neisseria meningitidis strains in Mali | Q84963070 |
| | Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity | Q43929104 |
| | The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002. | Q43932674 |
| | Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component | Q44509823 |
| | Global epidemiology of meningococcal disease. | Q44677055 |
| | Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine | Q47861269 |
| | Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. | Q51004314 |
| | Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002-2006. | Q52804410 |
| | No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales | Q58668811 |
| | Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger | Q60213378 |
| | Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex | Q64128132 |
| | Polymerase chain reaction for case ascertainment of meningococcal meningitis: application to the cerebrospinal fluids collected in the course of the Norwegian meningococcal serogroup B protection trial | Q71500018 |
| | Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine | Q24629949 |
| | CEREBROSPINAL MENINGITIS IN AFRICA | Q24643970 |
| | Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms | Q24685491 |
| | Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso | Q28744396 |
| | Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. | Q30329269 |
| | Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana | Q33280136 |
| | Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005 | Q33729202 |
| | Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis | Q33965603 |
| | Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes | Q34073348 |
| | Genetic study of capsular switching between Neisseria meningitidis sequence type 7 serogroup A and C strains | Q34119434 |
| | Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine | Q34191003 |
| | Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM). | Q34267478 |
| | Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data | Q34346578 |
| | Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine | Q34430626 |
| | Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda | Q34536636 |
| | PorA variable regions of Neisseria meningitidis | Q35880198 |
| | Lessons from meningococcal carriage studies | Q36711465 |
| | Systematic review: Impact of meningococcal vaccination on pharyngeal carriage of meningococci | Q36981703 |
| | Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains | Q37256462 |
| | Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003. | Q37473667 |
| | Meningitis serogroup W135 outbreak, Burkina Faso, 2002 | Q37473705 |
| | Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience | Q38011315 |
| | Epidemics caused by group X meningoccal meningitis in Africa in 2006 | Q38481963 |
| | Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae | Q38583289 |
| | Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa | Q39260913 |
| | Pharyngeal carriage of serogroup W135 Neisseria meningitidis in Hajjees and their family contacts in Morocco, Oman and Sudan | Q39303759 |
| | Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali | Q42282093 |
| | Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain | Q42547048 |
| | Populations of pharyngeal meningococci in Niger | Q43814164 |
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Burkina Faso | Q965 |
| P304 | page(s) | 363 | |
| P577 | publication date | 2013-08-02 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine | |
| P478 | volume | 13 | |